SpineX Announces First Patient Enrollment in SCONE Clinical Trial
SCONE trial is assessing safety and efficacy of the SCONE™ device for Neurogenic Bladder LOS ANGELES–(BUSINESS WIRE)–SpineX Inc., a clinical stage bioelectric medtech company, today announced that the first patient has been enrolled in a pivotal trial evaluating the SCONE™ Device. The pivotal trial, known as SCONE trial, will evaluate the safety and effectiveness of … [Read more…]
